In 2002 Schirmer received the "Dream Action Award" of the Dutch-based chemical corporation DSM for developing and clinically testing drug combinations containing methylene blue to combat malaria in West African children.
Also translated into Japanese ( タンパク質 : 構造・機能・進化 / Tanpakushits) and Russian, According to WorldCat, the book is held in 749 libraries[11] Gromer, Stefan; Arscott, L. David; Williams, Charles H.; Schirmer, R. Heiner; Becker, Katja (August 7, 1998), "Human placenta thioredoxin reductase.
Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds", Journal of Biological Chemistry, 273 (32): 20096–20101, doi:10.1074/jbc.273.32.20096, PMID 9685351 According to Google Scholar, this paper has been cited 406 times.
[12] Schirmer, R. Heiner; Müller, Joachim G.; Krauth-Siegel, R. Luise (3 February 1995), "Disulfide-reductase inhibitors as chemotherapeutic agents: The design of drugs for trypanosomiasis and malaria", Angewandte Chemie International Edition in English, 34 (2): 141–154, doi:10.1002/anie.199501411 According to Google Scholar, the paper has been cited 222 times.
Kanzok, Stefan M.; Fechner, Anke; Bauer, Holger; Ulschmid, Julia K.; Müller, Hans-Michael; Botella-Munoz, José; Schneuwly, Stephan; Schirmer, R. Heiner; Becker, Katja (26 Jan 2001), "Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster", Science, 291 (5504): 643–646, Bibcode:2001Sci...291..643K, doi:10.1126/science.291.5504.643, PMID 11158675 According to Google Scholar, it has been cited 336 times.